Bracco Imaging has obtained 510(k) clearance from the US Food and Drug Administration (FDA) and Health Canada authorisation for VueJect, a contrast delivery system designed for use in cardiology imaging.

VueJect is designed to support imaging procedures by delivering ultrasound contrast agents.

The device will be sold initially in the US and Canada, with further submissions planned in additional markets.